RE:RE:RE:RE:RE:RE:RE:I don't own shares. but I think this helps TBPGmack, lets be real here. You sir, are extremely biased. Similarily, is Leafy. Yes, share dilution is going to happen, its inevitable. Especially, considering Tetra is a paid subscriber to Stockhouse. Tetra is banking on recent news to drive up the SP, unfortunately its not happening. If you look at the financials they have a cash burn rate of 150,000$ month on average. I have no idea who to compare this stock too, when looking at cash burn rates. In my experience, I don't even think there's a Pharma company that would historically match its cash burn rate. It's that low.
Tetra won't have any issues finding a financial backer, but they may not like the offer they get. Some so-so news for those holding at the moment, regardless of the Share price the market ca,p its likely to hover around 100 million$ until trial data is released. If the trial data is good (not fantastic) you're looking at a share price that will double over night. That being said, if Tetra decides to issue more shares and dilute the share price further (They have no choice), you may find the SP at .50$ per share but the market cap will still remain the same at 100 million$. But, then boom, the sp doubles and you're looking at 1.00 with a market cap of 200 million$ As far as share dilution, they will need approximately 25 - 50 million$ or more in the next 2 years to get the ball rolling. I hope Tetra can get their act together. I DO BELIEVE (UNBIASED) A DIN# FOR SMOKEABLE MARIJUANA WITH FAIR to GOOD RESULTS WILL RESULT IN A 500 MILLION DOLLAR MARKET CAP FOR THIS COMPANY IN THE FIRST MONTH OF SUCCESSFULL STAGE 3 TRIALS. Why? Becasue, everything is riding on it and stage 3 trials on RxPrinceps is transferable to at least 3 other trials in their pipeline. THAT BEING SAID, THIS COMPANY IS ON TRACK TO BEING THE LOWEST COST FDA APPROVED DIN# IN THE HISORY OF PHARMA BASED DRUGS. THE CSO or GU CHAMBERLAND IS A VERY SMART MAN. USING KNOWN CLINCIAL SAFETY DATA TO BY PASS CLINICAL TRIALS IS BRILLIANT, MORE SO, CREATING OTHER TRIALS THAT HAVE TRANSFERABLE DATA (I.E. RX PRINCEPS AND OILS for example) IS SIMPLY AMAZING! YET, I WON'T INVEST. WHY, THE COMPANY IS INCOMPETENT. FIND ME A CEO THAT WILL DRIVE THIS COMPANY TO NEW HEIGHTS AND I'm IN! GUY CHAMBERLAND SHOULD FOCUS ON HIS PRIMARY JOB!!!!!! Not doing so, will slow down the trials. As evident, of the trails pace. I'd rather they have an interim-interim CEO than pull the only guy thats given this company any value.